Company Profile

Teleflex Stock Price, News & Catalysts

Ticker:
TFX
Exchange:
NYSE
Sector:
MedTech
Location:
United States

Stock performance

126.11 USD (+0.86%)

Close

Last updated: October 1, 2026

5.54B USD

Market cap

Why the stock is moving

As of Oct 1, 2026, TFX closed up 0.86% at $126.11. No new same-company headline was identified in the current news window.

Company overview

Diversified Medical Technology Company

Teleflex develops medical devices used in vascular access, interventional cardiology and radiology, surgery, anesthesia, emergency medicine, and urology. Its portfolio includes established brands such as Arrow, QuikClot, LMA, Weck, Barrigel, and Rüsch.

Vascular and Emergency Medicine

The vascular business includes central venous access, arterial access, intraosseous access, hemostatic products, and emergency-care technologies. EZPLAZ freeze-dried plasma extends the portfolio into a biologic product intended for settings where conventional plasma may be unavailable.

Interventional Portfolio

Teleflex's interventional business includes coronary and peripheral devices, catheter-based technologies, and the acquired BIOTRONIK vascular intervention portfolio. These products are used by interventional cardiologists and radiologists in minimally invasive procedures.

Surgical Products

The surgical portfolio includes ligation, closure, specialty instruments, and other products used in operating rooms. Brands such as Weck and Deknatel provide recurring demand across a broad range of procedures.

Freesolve Resorbable Scaffold

Freesolve is a drug-eluting resorbable magnesium scaffold designed to provide temporary vessel support and then dissolve. The program includes completed long-term follow-up, an ex-U.S. randomized study, and a U.S. pivotal trial.

Future catalysts

  • Late-2027 data readout from the randomized BIOMAG-II study of the Freesolve resorbable magnesium scaffold.

Recent news

  1. 01
  2. 02
  3. 03
  4. 04
  5. 05

Similar stocks

Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.

Frequently Asked Questions

What is the current stock price of Teleflex (TFX)?

Teleflex (TFX) most recently closed at 126.11 USD, a +0.86% move versus the previous session.

What is the market cap of Teleflex (TFX)?

Teleflex currently has a market capitalization of 5.54B USD on BioPharmSignal.

What does Teleflex do?

Diversified Medical Technology Company Teleflex develops medical devices used in vascular access, interventional cardiology and radiology, surgery, anesthesia, emergency medicine, and urology. Its portfolio includes established brands such as Arrow, QuikClot, LMA, Weck, Barrigel, and Rüsch. Vascular and Emergency Medicine The vascular business includes...

On which exchange is TFX stock listed?

Teleflex (TFX) is associated with NYSE, United States, MedTech.

What is BIOMAG-II?

Late-2027 data readout from the randomized BIOMAG-II study of the Freesolve resorbable magnesium scaffold.

Which conditions is Teleflex targeting with BIOMAG-II?

Late-2027 data readout from the randomized BIOMAG-II study of the Freesolve resorbable magnesium scaffold.

How does Teleflex describe recent progress with BIOMAG-II?

Late-2027 data readout from the randomized BIOMAG-II study of the Freesolve resorbable magnesium scaffold.

What is Diversified?

Diversified Medical Technology Company Teleflex develops medical devices used in vascular access, interventional cardiology and radiology, surgery, anesthesia, emergency medicine, and urology.